Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.06 +0.03 (+1.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Price to Sales (2021 - 2024)

Updated

Analysis

Acumen Pharmaceuticals (ABOS) Price to Sales (2021 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Acumen Pharmaceuticals 148.11 Mn -333.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 24.72
Sep 30, 2023 29.19
Jun 30, 2023 34.19
Mar 31, 2023 40.16
Dec 31, 2022 92.65
Sep 30, 2022 382.89
Jun 30, 2022 462.03
Mar 31, 2022 1,014.43
Dec 31, 2021 1,614.15
API Access

Acumen Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=ABOS&period=max&api_key=YOUR_API_KEY